CARE Ratings Ltd
CARE Ratings Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #19 of 22 in Capital Markets
See the sector's top 10 — free with your mobile number.
CARE Ratings Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 Operating Income: Rs. 164.13 Crs, up 20% YoY.
As stated in CARE Ratings Ltd's Q2 FY27 investor presentation · published 29 Oct 2026. Reported figures, not investment advice.
Based on CARE Ratings Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 Operating Income: Rs. Q2 FY27 EBITDA: Rs.
From CARE Ratings Ltd's Q2 FY27 earnings-call transcript · updated 29 Oct 2026.
Revenue & Sales Performance
2 more points from CARE Ratings Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.
CARE Ratings Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹112 Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- Computer Age Management Services Ltd (Q2 FY27)
Q2 FY’27 Revenue from operations: ₹41,446.57 Lakh, up 10.0% YoY (₹37,673.79 Lakh in Q2 FY’26). Key investor presentation takeaways from Computer Age Management
- ICRA (Q2 FY27)
Q2 FY2027 Group Revenue: ₹177.9 crore (up from ₹136.6 crore in Q2 FY2026) – ~30.2% YoY growth . Key investor presentation takeaways from ICRA Ltd's Q2 FY27 inve
- Motilal Oswal Financial Services Ltd (Q2 FY27)
Total Net Revenues for Q2FY27: ₹1,757 crore, up 20% YoY from ₹1,460 crore in Q2FY26 (Page 18). Key investor presentation takeaways from Motilal Oswal Financial
- Indian Energy Ex (Q2 FY27)
Total Revenue (Standalone) Q2 FY’27: Rs 203.0 Cr, up from Rs 183.3 Cr in Q2 FY’26 (~10.7% YoY growth) . Key investor presentation takeaways from Indian Energy E
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Nippon Life Ind.Good growth2
- BSEGood growth1
- Motil.Oswal.Fin.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q2 FY27 results?
Q2 FY27 Operating Income: Rs. Q2 FY27 EBITDA: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 27.5 with a market cap of ₹4,882 Cr. Investors should review the full earnings analysis for detailed insights.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.